2020.09.25 LOTUS RECEIVED TENTATIVE APPROVAL FOR ITS ANDA FOR LENALIDOMIDE FROM US FDA
2020.09.24 DEDICATES TO CORPORATE SUSTAINABILITY LOTUS RECEIVES ASIA RESPONSIBLE ENTERPRISE AWARDS
2020.09.18 LOTUS ANNOUNCES EXCLUSIVE COMMERCIALZIATION AGREEMENT WITH CKD FOR BIOSIMILAR DARBEPOETIN ALFA
2020.08.24 BY DONATION OF ACAMPROSATE LOTUS TO HELP ALCOHOLISM PATIENTS BACK TO NORMAL LIFE
2020.06.22 LOTUS PROVIDES A BUSINESS UPDATE FOR THE SEA MARKETS
2020.04.27 LOTUS ANNOUNCES NEW GLOBAL PARTNERSHIPS TO DRIVE GROWTH